Abiraterone is a medication used for advanced prostate cancer. It reduces the body's production of androgens that fuel tumor growth. The drug blocks the enzyme cyp17a1 which converts cholesterol into pregnenolone and subsequent sex hormones. By inhibiting this enzyme it lowers circulating testosterone and other androgens that stimulate cancer cells. The resulting hormonal suppression slows the progression of metastatic disease. Abiraterone is taken orally in combination with a low dose of prednisone to manage side effects. It functions without directly killing cancer cells but by removing the hormonal signals that promote their growth.

Abiraterone is an oral medication used to treat metastatic prostate cancer. It works by inhibiting the enzyme 17-alpha hydroxylase which reduces production of androgens. By lowering androgen levels it slows the growth of cancer cells that depend on these hormones. The drug specifically blocks the conversion of cholesterol into pregnenolone a key step in steroid synthesis. This inhibition leads to decreased activation of the androgen receptor in tumor tissues. The resulting hormonal suppression helps control disease progression in patients with advanced prostate cancer. Abiraterone's mechanism directly targets the biochemical pathway that fuels prostate tumor growth.

Abiraterone is a medication used in the treatment of certain types of cancer. Common side effects may include fatigue, nausea, and joint pain. Some patients experience an increase in liver enzymes that require monitoring by healthcare professionals. Hormonal changes from the drug can lead to hot flashes and decreased libido. Fluid retention may cause swelling in the ankles or feet in some individuals. Cardiovascular effects such as high blood pressure have been reported in clinical studies. Metabolic disturbances like low potassium levels can occur and are often checked through routine lab tests. These effects are generally manageable but may vary in severity among patients.

Abiraterone is a medication used to treat certain types of prostate cancer. Common side effects include hormonal changes such as hot flashes and decreased libido. Some patients experience liver enzyme elevations that may affect liver function tests. Fatigue and nausea are frequently reported during treatment. Edema or swelling of the lower extremities can occur in some individuals. Blood pressure may rise, requiring regular monitoring by healthcare providers.